Cargando…

Considerations and guidance in designing equity-relevant clinical trials

Health research has documented disparities in health and health outcomes within and between populations. When these disparities are unfair and avoidable they may be referred to as health inequities. Few trials attend to factors related to health inequities, and there is limited understanding about h...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbuagbaw, Lawrence, Aves, Theresa, Shea, Beverley, Jull, Janet, Welch, Vivian, Taljaard, Monica, Yoganathan, Manosila, Greer-Smith, Regina, Wells, George, Tugwell, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460332/
https://www.ncbi.nlm.nih.gov/pubmed/28583125
http://dx.doi.org/10.1186/s12939-017-0591-1
_version_ 1783242149093965824
author Mbuagbaw, Lawrence
Aves, Theresa
Shea, Beverley
Jull, Janet
Welch, Vivian
Taljaard, Monica
Yoganathan, Manosila
Greer-Smith, Regina
Wells, George
Tugwell, Peter
author_facet Mbuagbaw, Lawrence
Aves, Theresa
Shea, Beverley
Jull, Janet
Welch, Vivian
Taljaard, Monica
Yoganathan, Manosila
Greer-Smith, Regina
Wells, George
Tugwell, Peter
author_sort Mbuagbaw, Lawrence
collection PubMed
description Health research has documented disparities in health and health outcomes within and between populations. When these disparities are unfair and avoidable they may be referred to as health inequities. Few trials attend to factors related to health inequities, and there is limited understanding about how to build consideration of health inequities into trials. Due consideration of health inequities is important to inform the design, conduct and reporting of trials so that research can build evidence to more effectively address health inequities and importantly, ensure that inequities are not aggravated. In this paper, we discuss approaches to integrating health equity-considerations in randomized trials by using the PROGRESS Plus framework (Place of residence, Race/ethnicity/culture/language, Occupation, Gender, Religion, Education, Socio-economic status, Social capital and “Plus” that includes other context specific factors) and cover: (i) formulation of research questions, (ii) two specific scenarios relevant to trials about health equity and (iii) describe how the PROGRESS Plus characteristics may influence trial design, conduct and analyses. This guidance is intended to support trialists designing equity-relevant trials and lead to better design, conduct, analyses and reporting, by addressing two main issues: how to avoid aggravating inequity among research participants and how to produce information that is useful to decision-makers who are concerned with health inequities.
format Online
Article
Text
id pubmed-5460332
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54603322017-06-07 Considerations and guidance in designing equity-relevant clinical trials Mbuagbaw, Lawrence Aves, Theresa Shea, Beverley Jull, Janet Welch, Vivian Taljaard, Monica Yoganathan, Manosila Greer-Smith, Regina Wells, George Tugwell, Peter Int J Equity Health Commentary Health research has documented disparities in health and health outcomes within and between populations. When these disparities are unfair and avoidable they may be referred to as health inequities. Few trials attend to factors related to health inequities, and there is limited understanding about how to build consideration of health inequities into trials. Due consideration of health inequities is important to inform the design, conduct and reporting of trials so that research can build evidence to more effectively address health inequities and importantly, ensure that inequities are not aggravated. In this paper, we discuss approaches to integrating health equity-considerations in randomized trials by using the PROGRESS Plus framework (Place of residence, Race/ethnicity/culture/language, Occupation, Gender, Religion, Education, Socio-economic status, Social capital and “Plus” that includes other context specific factors) and cover: (i) formulation of research questions, (ii) two specific scenarios relevant to trials about health equity and (iii) describe how the PROGRESS Plus characteristics may influence trial design, conduct and analyses. This guidance is intended to support trialists designing equity-relevant trials and lead to better design, conduct, analyses and reporting, by addressing two main issues: how to avoid aggravating inequity among research participants and how to produce information that is useful to decision-makers who are concerned with health inequities. BioMed Central 2017-06-05 /pmc/articles/PMC5460332/ /pubmed/28583125 http://dx.doi.org/10.1186/s12939-017-0591-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Mbuagbaw, Lawrence
Aves, Theresa
Shea, Beverley
Jull, Janet
Welch, Vivian
Taljaard, Monica
Yoganathan, Manosila
Greer-Smith, Regina
Wells, George
Tugwell, Peter
Considerations and guidance in designing equity-relevant clinical trials
title Considerations and guidance in designing equity-relevant clinical trials
title_full Considerations and guidance in designing equity-relevant clinical trials
title_fullStr Considerations and guidance in designing equity-relevant clinical trials
title_full_unstemmed Considerations and guidance in designing equity-relevant clinical trials
title_short Considerations and guidance in designing equity-relevant clinical trials
title_sort considerations and guidance in designing equity-relevant clinical trials
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460332/
https://www.ncbi.nlm.nih.gov/pubmed/28583125
http://dx.doi.org/10.1186/s12939-017-0591-1
work_keys_str_mv AT mbuagbawlawrence considerationsandguidanceindesigningequityrelevantclinicaltrials
AT avestheresa considerationsandguidanceindesigningequityrelevantclinicaltrials
AT sheabeverley considerationsandguidanceindesigningequityrelevantclinicaltrials
AT julljanet considerationsandguidanceindesigningequityrelevantclinicaltrials
AT welchvivian considerationsandguidanceindesigningequityrelevantclinicaltrials
AT taljaardmonica considerationsandguidanceindesigningequityrelevantclinicaltrials
AT yoganathanmanosila considerationsandguidanceindesigningequityrelevantclinicaltrials
AT greersmithregina considerationsandguidanceindesigningequityrelevantclinicaltrials
AT wellsgeorge considerationsandguidanceindesigningequityrelevantclinicaltrials
AT tugwellpeter considerationsandguidanceindesigningequityrelevantclinicaltrials